// App-Quantinova.ai

3975 : Outcome of Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) By Age Group over 35 Years: A Single Institution Experience

Researchers

Presenter

  • Koji Sasaki

Principal Investigators

  • Susan M. -Brien

  • Gautam Borthakur

  • Tapan M. Kadia

  • Marina Konopleva

  • Maria R. Khouri

  • Alessandra Ferrajoli

  • Naval G. Daver

  • Naveen Pemmaraju

  • Courtney D. DiNardo

  • Nitin Jain

  • Christopher B. Benton

  • Deborah A Thomas

  • Koichi Takahashi

  • Kiran Naqvi

  • Prithviraj Bose

  • Steven M. Kornblau

  • Michael Andreeff

  • Michael J. Keating

  • Emil J. Freireich

  • Hagop M. Kantarjian

  • Farhad Ravandi

  • Guillermo Garcia-Manero

  • Jorge E. Cortes

  • Nicholas J. Short

  • Srdan Verstovsek

  • Musa Yilmaz

  • William G. Wierda

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

  • The Scott Department of Urology, Baylor College of Medicine, Houston, TX

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Chao Family Comprehensive Cancer Center, University of California, Orange, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved